New Inhaled Drug Shows Promise Against Asthma, Allergies – HealthDay


LiveScience.com

New Inhaled Drug Shows Promise Against Asthma, Allergies
HealthDay
WEDNESDAY, July 2, 2014 (HealthDay News) — A new inhaled medication has the potential to treat mild asthma and allergies by interrupting the production of an immune system protein that triggers allergic reactions, a new study reports. The drug …
Roche biotech drug offers new way to fight asthmaReuters
Candidate asthma and allergy drug passes early testScience News (blog)
Experimental Asthma Drug Hits a New TargetLiveScience.com

all 12 news articles »

View full post on asthma – Google News

Novel Antibody Demonstrates Promise against Asthma – Genetic Engineering News

Novel Antibody Demonstrates Promise against Asthma
Genetic Engineering News
Scientists at St. Joseph's Healthcare Hamilton and McMaster University report that they successfully tested an antibody (AMG 157) that can improve the quality of life for individuals with asthma by relieving inflammation in the lungs. The study
Amgen drug for allergy asthma shows promise in early testsSFGate
Novel Biologic Promising for Allergic AsthmaMedPage Today
New antibody can improve quality of life for individuals with asthmaNews-Medical.net
Daily Digest –CTV News
all 27 news articles »

View full post on asthma – Google News

Amgen drug for allergy asthma shows promise in early tests – SFGate

Amgen drug for allergy asthma shows promise in early tests
SFGate
An experimental compound from Amgen Inc. succeeded in blunting allergic asthma attacks by blocking a protein newly found to cause symptoms, researchers said. The drug, called AMG 157, focuses on a signaling protein known as thymic stromal …
Novel Biologic Promising for Allergic AsthmaMedPage Today
New antibody can improve quality of life for individuals with asthmaNews-Medical.net
New Amgen drug shows early promise for managing allergic asthma attacksDaily Digest
CTV News
all 25 news articles »

View full post on asthma – Google News

Tiotropium as Asthma Add-On Treatment Shows Promise – Monthly Prescribing Reference

Tiotropium as Asthma Add-On Treatment Shows Promise
Monthly Prescribing Reference
Boehringer Ingelheim has announced positive results from several Phase 3 studies analyzing once-daily tiotropium (Spiriva; Boehringer Ingelheim) delivered via the Respimat inhaler as an add-on treatment for asthma patients who remain symptomatic with 
Phase III studies show tiotropium delivered via Respimat inhaler proves News-Medical.net

all 4 news articles »

View full post on asthma – Google News

Asthma medicine shows promise for Down syndrome in mice tests [Updated] – Los Angeles Times


Counsel & Heal

Asthma medicine shows promise for Down syndrome in mice tests [Updated]
Los Angeles Times
A federally approved drug already being inhaled by asthma patients may make mice with Down syndrome smarter, according to a new study. Researchers chose to test the widely manufactured bronchodilator, Formoterol, because it also acts on a brain 
Using Asthma Medication, Scientists Improve Cognitive Function in Mouse Medical Daily
Asthma Meds May Boost Cognition in Down Syndrome PatientsCounsel & Heal
Drug improves cognitive function in mouse model of Down syndrome, study saysScope (blog)

all 6 news articles »

View full post on asthma – Google News

Asthma medicine shows promise for Down syndrome in mice tests – Los Angeles Times

Asthma medicine shows promise for Down syndrome in mice tests
Los Angeles Times
The dose was far above the quantity deemed safe for asthma use in humans. Before even considering human trials, researchers will have to reduce that dosage and see if its positive effects remain. Still, the path to prescription could be shorter because
Drug improves cognitive function in mouse model of Down syndrome, Stanford Science Codex

all 2 news articles »

View full post on asthma – Google News